Mark A. Moyad, MD, MPH, presented “Men’s Health & My World from A-to-Z: What is New, Old, Hot, or Cold?” during the 32nd Annual International Prostate Cancer Update (IPCU32) conference on March 8, 2022, in Snowbird, Utah.

How to cite: Moyad, Mark A. “Men’s Health & My World from A-to-Z: What is New, Old, Hot, or Cold?” March 8, 2022. Accessed Aug 2022.

Men’s Health & My World from A-to-Z: What is New, Old, Hot, or Cold? – Summary

Mark A. Moyad, MD, MPH, the Jenkins/Pokempner Director of Preventive/Complementary and Alternative Medicine (CAM) in the Department of Urology at the University of Michigan Medical Center in Ann Arbor, Michigan, reports on the latest trends in men’s health and related research. Covering topics from blood pressure to vitamin D, Dr. Moyad brings levity to the array of topics with a “hot or not” rating. He first discusses new research on acetaminophen, which has previously enjoyed a reputation as a heart-heathy drug, but was found to increase blood pressure by 4g/day vs. placebo. Dr. Moyad then highlights the value of flexibility in dietary restrictions with a review of the CALERIE trial. A cardiovascular trial, non-obese participants started with a 25% calorie reduction diet, but were allowed to choose how they reduced their calorie intake. At the end of the day, participants only succeeded in reducing an average of 13% or 250 calories a day, but lost an average of 15 pounds and showed improvement in heart health indicators. Next, he discusses how a regime of high intensity interval training (HIIT) workouts three times a week for 12 weeks led to decreased prostate-specific antigen (PSA) levels in men undergoing active surveillance in the ERASE trial. Dr. Moyad argues that the quality-of-life improvement in these patients is just as important to overall health. He then describes research on the side benefits of adult vaccines, including COVID and shingles vaccines, explaining that a reduction in inflammation from a serious infection can prevent future health problems. Last, Dr. Moyad discusses the role vitamin D may play in auto-immune disease prevention.

About the 32nd Annual International Prostate Cancer Update (IPCU32):
Presented by Program Chair E. David Crawford, MD,  The International Prostate Cancer Update (IPCU), is a multi-day, CME-accredited conference focused on new developments in prostate cancer treatment, diagnosis, and prevention. IPCU 32 featured lectures, interactive discussions, panel roundtables, debates, and case reports. This conference was led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer.